Kumari R,Kanika J,Debasis D .2018 .Comparison of clinical outcomes in clomiphene citrate resistant infertile polycystic ovarian syndrome women after treatment with laparoscopic ovarian drilling (LOD) versus gonadotropins. Int J Reprod Contracept Obstet Gynecol, 7(4) : 2320-1770.
Katsigianni M,Karageorgiou V,Lambrinoudaki I,Siristatidis C .2019 .Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatr, 24(12) : 1787-97.
Tan IF,Lim AJ,Indran IR,Kramer MS,Yong EL .2019 .Reproductive outcomes of women with polycystic ovarian syndrome following in-vitro fertilization - a meta-analysis and systematic review. Fertil Reprod, 01(4) : 193-201.
Estes JL,Pereira N,Lekovich J,Spandorfer SD .2016 .Perinatal outcomes of singletons following in vitro fertilization in women with polycystic ovarian syndrome [22G]. Obst Gyn, 0000483906(4) : 64S-5.
Chen YH,Wang Q,Zhang YN,Han X,Li DH,Zhang CL .2017 .Cumulative live birth and surplus embryo incidence after frozen-thaw cycles in PCOS: how many oocytes do we need?. J Assist Reprod Genet, 34(9) : 1153-9.
Moini A,Pirjani R,Rabiei M,Nurzadeh M,Sepidarkish M,Hosseini R .2019 .Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study. J Ovarian Res, 12(1) : 1-7.
Hafizi L,Behrouznia A,Amirian M,Baradaran M,Pourhoseini SA .2020 .Evaluation of anti-mullerian hormone predictive value and antral follicle count in the success rate of ovarian drilling in polycystic ovary syndrome. Shiraz E Med, 21(6) : .
Chiofalo F,Ciuoli C,Formichi C,Selmi F,Forleo R,Neri O .2017 .Bariatric surgery reduces serum anti-mullerian hormone levels in obese women with and without polycystic ovarian syndrome. Obes Surg, 27(7) : 1750-4.
Köninger A,Kampmeier A,Mach P,Schmidt B,Strowitzki T,Kimmig R .2018 .Tight interplay in early pregnancy between follistatin and anti-mullerian hormone in women with polycystic ovarian syndrome (PCOS). Arch Gynecol Obstet, 297(5) : 1307-16.
Al-Gareeb AI,Abd Al-Amieer WS,Alkuraishy HM,Al-Mayahi TJ .2016 .Effect of body weight on serum homocysteine level in patients with polycystic ovarian syndrome: a case control study. Int J Reprod Biomed, 14(2) : 81.
Kim J,Mersereau JE,Khankari N,Bradshaw PT,McCullough LE,Cleveland R .2016 .Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study. Cancer Cause Control, 27(3) : 403-14.
Pereira N,Lekovich J,Rosenwaks Z,Spandorfer SD .2015 .Do serum anti-Mullerian hormone levels correlate with pregnancy outcomes in patients with diminished ovarian reserve undergoing in vitro fertilization? Fertil Steril. , 07(3) : .
Simões-Pereira J,Nunes J,Aguiar A,Sousa S,Rodrigues C,Matias JS .2018 .Influence of body mass index in antiMüllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocrine, 61(1) : 144-8.
Kocaay P,Siklar Z,Buyukfirat S,Berberoglu M. .2018 .The diagnostic value of anti-mullerian hormone in early post menarche adolescent girls with polycystic ovarian syndrome. J Pediatr Adol Gynec, 02(4) : 362-6.
Vagios S,Sacha CR,Hsu JY,Dimitriadis I,Bormann CL,James KE .2019 .Can anti-mullerian hormone (AMH) levels predict response to ovulation induction treatments in women with polycystic ovarian syndrome (PCOS)? Fertil Steril. , 07(3) : e391-2.
de Loos AD,Hund M,Buck K,Meun C,Sillman J,Laven JS .2019 .Establishing an anti-müllerian hormone (AMH) cut-off to determine polycystic ovarian morphology (PCOM) supporting diagnosis of polycystic ovarian syndrome (PCOS): the aphrodite study. Fertil Steril, 07(3) : .
Ishii R,Tachibana N,Okawa R,Enomoto M,Asami M,Toriumi R .2019 .Different anti-Mallerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): clues to better ART outcomes. Reprod Med Biol, 18(3) : 263-72.
Cai WY,Gao JS,Luo X,Ma HL,Ge H,Liu N .2019 .Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial. J Endocrinol Invest, 42(5) : 549-55.
Bedenk J,Vrtačnik-Bokal E,Virant-Klun I. .2020 .The role of antiMüllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet, 37(1) : 89-100.
Detti L,Williams LJ,Osborne SE,Fletcher NM,Saed GM .2015 .LH-receptors and Inhibin-B production. Fertil Steril, 07(3) : .
Li G,Huang W,Zhang L,Tian Z,Zheng W,Wang T .2018 .A prospective cohort study of early-pregnancy risk factors for gestational diabetes in women with polycystic ovarian syndrome. Diabetes Metab Res, 34(5) : .
Cree-Green M,Cai N,Thurston JE,Coe GV,Newnes L,GarciaReyes Y .2018 .Using simple clinical measures to predict insulin resistance or hyperglycemia in girls with polycystic ovarian syndrome. Pediatr Diabetes, 19(8) : 1370-8.
Pergialiotis V,Trakakis E,Chrelias C,Papantoniou N,Hatziagelaki E. .2018 .The impact of mild hypercholesterolemia on glycemic and hormonal profiles, menstrual characteristics and the ovarian morphology of women with polycystic ovarian syndrome. -0002, 34(3) : 1-7.
Melado Vidales L,Fernández-Nistal A,Martínez Fernández V,Verdú Merino V,Bruna Catalán I .2017 .AntiMüllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation. Minerva Ginecol, 69(3) : 03958-7.